Recombinant human antithrombin III: rhATIII

Drugs in R and D

Volumn 5, Issue 2, 2004, Pages 110-112

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; HEPARIN; PLACEBO; RECOMBINANT ANTITHROMBIN III;

ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; THROMBOSIS;

ANIMALS; ANTITHROMBIN III; CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HUMANS; RECOMBINANT PROTEINS; RESPIRATORY TRACT DISEASES;

EID: 2342661722     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405020-00009     Document Type: Article

References (9)

1. GTC Biotherapeutics Inc. GTC Biotherapeutics Restructures to Support Commercialization Programs. Media Release 4 Feb 2004. Available from URL: http://www.gtc-bio.com
2. Lu W, Mant TGK, Levy JH, et al. Pharmacokinetics of recombinant transgenic antithrombin in volunteers. Anesthesia and Analgesia 90: 531-534, Mar 2000
3. Tait RC, Walker ID, Makris M, et al. Pharmacokinetics of recombinant human antithrombin in hereditary antithrombin-deficient patients. Blood Coagulation and Fibrinolysis 13: A10, Dec 2002
4. GTC Biotherapeutics Inc. GTC's rhATIII Used in Preclinical Study of Acute Lung Injury Treatment. Media Release 2 Apr 2003. Available from URL: http://www.gtc-bio.com
5. GTC Biotherapeutics Inc. GTC Biotherapeutics Announces Presentations of Patient and Process Data on rhATIII at the 47th Annual Meeting of the Society of Thrombosis and Haemostasis Research. Media Release 18 Feb 2003. Available from URL: http:/www.gtc-bio.com
6. Genzyme transgenics, Genzyme General announce transgenic ATIII trial results. PR Newswire [online; 3 pages], 9 Dec 1997. Available from http://www.newspage.com
7. Levy JH, Despotis GH, Olson P. Transgenically produced recombinant human ATII enhances the antithrombotic effects of heparin in patients undergoing cardiac surgery. Blood 90 (Suppl. 1): 298, Part 1, 15 Nov 1997
8. Genzyme General. Genzyme Transgenics and Genzyme General announce phase III data on rhATII. Media Release [2 pages], 10 Jan 2000. Available from URL: http://www.genzyme.com
9. Genzyme Transgenics Corporation, Genzyme General. Genzyme Transgenics and Genzyme General announce rhATIII phase III study results. Media Release [3 page], 7 Sep 2000. Available from URL: http://www.transgenics.com